Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susann Varano

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Comparative Effectiveness Research|August 16, 2023
Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?Jeffrey Frankel, David Staskin, Susann Varano, et al.
Neurourology and Urodynamics|October 24, 2020
Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta-analysisRoger R Dmochowski, Sydney Thai, Kristy Iglay, et al.
International Journal of Clinical Practice|June 10, 2022
Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR TrialDavid Staskin, Jeffrey Frankel, Susann Varano, et al.
Advances in Therapy|December 18, 2021
Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWURJeffrey Frankel, David Staskin, Susann Varano, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Comparative Effectiveness Research|August 16, 2023
Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?Jeffrey Frankel, David Staskin, Susann Varano, et al.
Neurourology and Urodynamics|October 24, 2020
Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta-analysisRoger R Dmochowski, Sydney Thai, Kristy Iglay, et al.
International Journal of Clinical Practice|June 10, 2022
Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR TrialDavid Staskin, Jeffrey Frankel, Susann Varano, et al.
Advances in Therapy|December 18, 2021
Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWURJeffrey Frankel, David Staskin, Susann Varano, et al.
Pageof 2